Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia

Clinical trial NCT00233454 · COMPLETED

Trial details

NCT number: NCT00233454
Sponsor: Jason Robert Gotlib
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Mastocytosis, Aggressive (ASM)Leukemia, Mast Cell Hematological Non-mast Cell Lineage Disease (AHNMD)

Start date: 2005-03-01
Primary completion: 2010-06-18
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.